AAVantgarde is now initiating ‘CELESTE’, a first-in-human Phase 1/2 clinical trial in the United States, to evaluate the safety, tolerability, and initial efficacy of AAVB-039 in patients with ...

Singapore’s PRL3-zumab, a cancer drug, shows promise in treating eye diseases like AMD and diabetic retinopathy, offering ...

Q: I used to be a serious exerciser, but now that I am in my late 60s, I find it harder and harder to stay on track. Got any words ...